Stämm Vegh SA develops solutions for biomanufacturing, bioengineering and bio‑AI to support biologics and cell therapy production and cell line development. Its offerings include a plug‑and‑play continuous bioreactor (the Bioprocessor) with a bubble‑free bioreactor, automated cell‑line engineering and clone‑selection platforms, and MoNA™ — a transomics platform for multi‑omic analysis and in‑silico cell simulation.
AI-generated
Offering
Products & services
Industry:Pharmaceutical Industry
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Plug & play continuous biomanufacturing with automated, closed-loop production, parallelized homogeneous run conditions, cloud control, and a high-throughput bioprocessor for biologics and cell therapies.
Bioengineering
End-to-end solutions for cell line development, including automated cell engineering, clone outgrowth, clone selection and screening for biologics production.
Bio AI
Multi-omic data analysis and cell-predictive pipelines using AI generative models, including in-silico modelling, assay support, and environmental parameter recommendations.
Knowledge
No knowledge articles yet
Once Stämm Vegh SA has claimed this profile, we'll publish editorial articles and case studies here together.